Ocular Therapeutix, Inc
OCUL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001393434
In the last 90 days, Ocular Therapeutix, Inc insiders filed 0 open-market purchases and 5 sales; 262 institutions reported holding it in 13F filings for Q2 2026, worth $2.03B in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding Ocular Therapeutix, Inc changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 130 | 116 | −14 |
| Shares | 42.8M | 39.6M | −3.15M (−7.4%) |
| Value | $177.6M | $111.3M | −$66.3M (−37.3%) |
New holders (12)
Institutions that held Ocular Therapeutix, Inc at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Tejara Capital Ltd | 102,457 | $287.9K | 0.17% |
| Caption Management, LLC | 25,000 | $70.3K | 0.01% |
| Balyasny Asset Management LLC | 24,991 | $70.2K | 0.00% |
| Vontobel Holding Ltd. | 24,000 | $67.4K | 0.00% |
| Covestor Ltd | 16,659 | $47.0K | 0.04% |
| Belpointe Asset Management LLC | 12,550 | $35.3K | 0.00% |
| HSBC Holdings PLC | 11,940 | $32.9K | 0.00% |
| Trust Co of Vermont | 4,000 | $11.2K | 0.00% |
| Money Concepts Capital Corp | 1,000 | $2.81K | 0.00% |
| Quent Capital, LLC | 490 | $1.38K | 0.00% |
| Advisory Services Network, LLC | 250 | $703 | 0.00% |
| Sofos Investments, Inc. | 3 | $6 | 0.00% |
Sold out (26)
Institutions that held Ocular Therapeutix, Inc at the end of Q3 2022 and filed for Q4 2022 without it.